About 30% of COVID Patients Develop “Long COVID” – Here’s Who Is Most at Risk
New University of California, Los Angeles (UCLA) research finds that 30% of people treated for COVID-19 developed Post Acute Sequelae of COVID-19 (PASC), most commonly…
UCLA Health
Levels of a Hormone Could Predict or Detect Bone Loss in Premenopausal Women
Physicians may be able to determine if menopause-related bone loss is already in progress or about to begin by measuring the level of a hormone…
Treatment of Long COVID Hampered by a Critical Issue
Researchers say treatment of long COVID could be hampered by lack of consensus in identifying and diagnosing the condition. In a new report, researchers say…
UCLA Breakthrough Points Way to Longer-Lasting COVID Vaccine
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that…
Combination of Natural Infection and Vaccination Provides Maximum Protection Against COVID Variants
A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds. The…
How Brain Cells Compensate for Damage From a Stroke – New Results Challenge Current Ideas
New results challenge the current model of how the brain can reorganize in the aftermath of stroke damage. A study from UCLA neurologists challenges the…
Vaping Just Once Raises Oxidative Stress Levels in Healthy Nonsmokers – Increases Disease Risk
New study findings ‘are clear, unambiguous and concerning,’ UCLA researcher says. The risk that both tobacco and electronic cigarettes can pose to regular smokers’ health…
RNA Modification May Protect Against Fatty Liver Disease
May also explain liver fat differences among men & women. A chemical modification that occurs in some RNA molecules as they carry genetic instructions from…
Experimental Gene Therapy Cures Children Born Without an Immune System in Clinical Trials
Study shows treatment developed by international team restored immune function in more than 95% of patients in three clinical trials. An experimental form of gene…
Scientists Develop High Performance Mitochondria Transfer Device
Method will help researchers better understand mitochondrial DNA diseases. Scientists from the UCLA Jonsson Comprehensive Cancer have developed a simple, high-throughput method for transferring isolated…
The One Day of the Year to Avoid Surgery – 23% Higher Mortality Risk
Study shows higher mortality rates for those needing emergency procedures on their surgeon’s birthday. Older people who undergo emergency surgeries on their operating surgeon’s birthday…
UCLA Scientists Discover How the COVID-19 Virus Causes Multiple Organ Failure
UCLA researchers are the first to create a version of COVID-19 in mice that shows how the disease damages organs other than the lungs. Using…
New Study Shows COVID-19 May Have Spread in Los Angeles As Early as Last December
Researchers detected an unexpected 50% increase in patients presenting with respiratory illnesses at UCLA Health facilities in the months before the pandemic. UCLA researchers and…
Immunity Against Cancer? Engineered Killer T Cells May Be the Key.
UCLA researchers use stem cells to engineer cells that attack human tumors in mice. They’ve been called the “special forces” of the immune system: invariant…
Experimental Brain Implant Restores Visual Perception to the Blind [Video]
With wireless device, patients can detect motion, distinguish light and dark. Of the nearly 39 million people worldwide who are legally blind, many were born…
